Last 12 months
Inside the activity.
0 purchase rows · 59 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 26 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 14 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 17, 2026 20:47 UTC |
PYOTT DAVID E IDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 201 | $0.00 | $0.00 |
DisclosureSEC source: 0001051578-26-000010 · wk-form4_1789678066.xml · derivative · entry 2 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 605 Underlying: Common Stock · 201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:47 UTC |
PYOTT DAVID E IDirector
|
Exercise / conversionCommon Stock | 201 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001051578-26-000010 · wk-form4_1789678066.xml · nonDerivative · entry 1 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the David E.I. Pyott Trust Disclosed balance after: 9,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. F2 · balance_after: Includes 1,383 shares previously owned directly that were transferred to the reporting person's trust on May 14, 2026. There was no change in the reporting person's pecuniary interest in the shares. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:22 UTC |
LINK WILLIAM J PHDDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 201 | $0.00 | $0.00 |
DisclosureSEC source: 0001228684-26-000010 · wk-form4_1789676560.xml · derivative · entry 5 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 605 Underlying: Common Stock · 201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F6 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. F6 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:22 UTC |
LINK WILLIAM J PHDDirector
|
SaleCommon Stock | 66 | $80.01 | $5,280.66 |
DisclosureSEC source: 0001228684-26-000010 · wk-form4_1789676560.xml · nonDerivative · entry 4 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,487 F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:22 UTC |
LINK WILLIAM J PHDDirector
|
SaleCommon Stock | 759 | $79.00 | $59,961.00 |
DisclosureSEC source: 0001228684-26-000010 · wk-form4_1789676560.xml · nonDerivative · entry 3 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,553 F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025. F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $78.89 to $79.10. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:22 UTC |
LINK WILLIAM J PHDDirector
|
SaleCommon Stock | 11,675 | $78.33 | $914,502.75 |
DisclosureSEC source: 0001228684-26-000010 · wk-form4_1789676560.xml · nonDerivative · entry 2 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,312 F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025. F3 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $77.87 to $78.86. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:22 UTC |
LINK WILLIAM J PHDDirector
|
Exercise / conversionCommon Stock | 201 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001228684-26-000010 · wk-form4_1789676560.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:22 UTC |
YARNO WENDY LDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 302 | $0.00 | $0.00 |
DisclosureSEC source: 0001181186-26-000008 · wk-form4_1789676577.xml · derivative · entry 2 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 907 Underlying: Common Stock · 302 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 20:22 UTC |
YARNO WENDY LDirector
|
Exercise / conversionCommon Stock | 302 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001181186-26-000008 · wk-form4_1789676577.xml · nonDerivative · entry 1 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 20:14 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 2,900 | $91.27 | $264,683.00 |
DisclosureSEC source: 0001827672-26-000013 · wk-form4_1788984881.xml · nonDerivative · entry 2 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Plan reported Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 827,991 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $91.06 to $91.45. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 20:14 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 7,100 | $90.27 | $640,917.00 |
DisclosureSEC source: 0001827672-26-000013 · wk-form4_1788984881.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Plan reported Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 830,891 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $90.00 to $90.91. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 20:13 UTC |
Lin Elizabeth YeuChief Medical Officer
|
SaleCommon Stock | 1,590 | $90.00 | $143,100.00 |
DisclosureSEC source: 0001842190-26-000011 · wk-form4_1788984804.xml · nonDerivative · entry 4 Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse's Roth IRA Disclosed balance after: 1,590 F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 20:13 UTC |
Lin Elizabeth YeuChief Medical Officer
|
SaleCommon Stock | 1,590 | $85.00 | $135,150.00 |
DisclosureSEC source: 0001842190-26-000011 · wk-form4_1788984804.xml · nonDerivative · entry 3 Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse's Roth IRA Disclosed balance after: 3,180 F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 20:13 UTC |
Lin Elizabeth YeuChief Medical Officer
|
SaleCommon Stock | 5,386 | $90.00 | $484,740.00 |
DisclosureSEC source: 0001842190-26-000011 · wk-form4_1788984804.xml · nonDerivative · entry 2 Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,547 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 20:13 UTC |
Lin Elizabeth YeuChief Medical Officer
|
SaleCommon Stock | 5,387 | $85.00 | $457,895.00 |
DisclosureSEC source: 0001842190-26-000011 · wk-form4_1788984804.xml · nonDerivative · entry 1 Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,933 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 20:12 UTC |
Neervannan SeshadriChief Operating Officer
|
SaleCommon Stock | 4,564 | $85.00 | $387,940.00 |
DisclosureSEC source: 0001827584-26-000013 · wk-form4_1788984767.xml · nonDerivative · entry 1 Neervannan Seshadri · CIK 0001827584 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,532 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 13, 2025. F2 · balance_after: Includes 305 shares acquired under the Issuer's Employee Stock Purchase Plan on June 30, 2026. Read SEC document |
| September 02, 2026 Filed Sep 3, 2026 20:30 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 10,000 | $80.06 | $800,600.00 |
DisclosureSEC source: 0001827672-26-000011 · wk-form4_1788467407.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Plan reported Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 837,991 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $80.00 to $80.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| September 02, 2026 Filed Sep 3, 2026 20:29 UTC |
Lin Elizabeth YeuChief Medical Officer
|
SaleCommon Stock | 1,590 | $80.00 | $127,200.00 |
DisclosureSEC source: 0001842190-26-000009 · wk-form4_1788467389.xml · nonDerivative · entry 3 Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse's Roth IRA Disclosed balance after: 4,770 F2 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2026. Read SEC document |
| September 02, 2026 Filed Sep 3, 2026 20:29 UTC |
Lin Elizabeth YeuChief Medical Officer
|
SaleCommon Stock | 5,387 | $80.00 | $430,960.00 |
DisclosureSEC source: 0001842190-26-000009 · wk-form4_1788467389.xml · nonDerivative · entry 2 Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,320 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:29 UTC |
Lin Elizabeth YeuChief Medical Officer
|
SaleCommon Stock | 4,601 | $73.86 | $339,829.86 |
DisclosureSEC source: 0001842190-26-000009 · wk-form4_1788467389.xml · nonDerivative · entry 1 Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,707 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2026. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:30 UTC |
PYOTT DAVID E IDirector
|
GrantRestricted Stock Units · Derivative | 806 | $0.00 | $0.00 |
DisclosureSEC source: 0001051578-26-000008 · wk-form4_1782765056.xml · derivative · entry 3 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 806 Underlying: Common Stock · 806 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:30 UTC |
PYOTT DAVID E IDirector
|
GrantRestricted Stock Units · Derivative | 2,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001051578-26-000008 · wk-form4_1782765056.xml · derivative · entry 2 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,417 Underlying: Common Stock · 2,417 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:30 UTC |
PYOTT DAVID E IDirector
|
GrantStock Option (right to buy) · Derivative | 3,837 | $0.00 Strike: $64.34 | $0.00 |
DisclosureSEC source: 0001051578-26-000008 · wk-form4_1782765056.xml · derivative · entry 1 PYOTT DAVID E I · CIK 0001051578 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,837 Underlying: Common Stock · 3,837 shares Expires 2036-06-24 F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:32 UTC |
Goodrich KatherineDirector
|
GrantRestricted Stock Units · Derivative | 2,417 | $0.00 | $0.00 |
DisclosureSEC source: 0002044770-26-000008 · wk-form4_1782765122.xml · derivative · entry 2 Goodrich Katherine · CIK 0002044770 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,417 Underlying: Common Stock · 2,417 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:32 UTC |
Goodrich KatherineDirector
|
GrantStock Option (right to buy) · Derivative | 3,837 | $0.00 Strike: $64.34 | $0.00 |
DisclosureSEC source: 0002044770-26-000008 · wk-form4_1782765122.xml · derivative · entry 1 Goodrich Katherine · CIK 0002044770 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,837 Underlying: Common Stock · 3,837 shares Expires 2036-06-24 F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:31 UTC |
Goldberg Andrew D.Director
|
GrantRestricted Stock Units · Derivative | 2,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001827722-26-000004 · wk-form4_1782765110.xml · derivative · entry 2 Goldberg Andrew D. · CIK 0001827722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,417 Underlying: Common Stock · 2,417 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:31 UTC |
Goldberg Andrew D.Director
|
GrantStock Option (right to buy) · Derivative | 3,837 | $0.00 Strike: $64.34 | $0.00 |
DisclosureSEC source: 0001827722-26-000004 · wk-form4_1782765110.xml · derivative · entry 1 Goldberg Andrew D. · CIK 0001827722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,837 Underlying: Common Stock · 3,837 shares Expires 2036-06-24 F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:31 UTC |
Morrison Scott WDirector
|
GrantRestricted Stock Units · Derivative | 2,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001662426-26-000006 · wk-form4_1782765098.xml · derivative · entry 2 Morrison Scott W · CIK 0001662426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,417 Underlying: Common Stock · 2,417 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:31 UTC |
Morrison Scott WDirector
|
GrantStock Option (right to buy) · Derivative | 3,837 | $0.00 Strike: $64.34 | $0.00 |
DisclosureSEC source: 0001662426-26-000006 · wk-form4_1782765098.xml · derivative · entry 1 Morrison Scott W · CIK 0001662426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,837 Underlying: Common Stock · 3,837 shares Expires 2036-06-24 F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:31 UTC |
CHAUDHURI BHASKARDirector
|
GrantRestricted Stock Units · Derivative | 2,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001458643-26-000004 · wk-form4_1782765084.xml · derivative · entry 2 CHAUDHURI BHASKAR · CIK 0001458643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,417 Underlying: Common Stock · 2,417 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:31 UTC |
CHAUDHURI BHASKARDirector
|
GrantStock Option (right to buy) · Derivative | 3,837 | $0.00 Strike: $64.34 | $0.00 |
DisclosureSEC source: 0001458643-26-000004 · wk-form4_1782765084.xml · derivative · entry 1 CHAUDHURI BHASKAR · CIK 0001458643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,837 Underlying: Common Stock · 3,837 shares Expires 2036-06-24 F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:31 UTC |
YARNO WENDY LDirector
|
GrantRestricted Stock Units · Derivative | 1,209 | $0.00 | $0.00 |
DisclosureSEC source: 0001181186-26-000006 · wk-form4_1782765069.xml · derivative · entry 3 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,209 Underlying: Common Stock · 1,209 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:31 UTC |
YARNO WENDY LDirector
|
GrantRestricted Stock Units · Derivative | 2,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001181186-26-000006 · wk-form4_1782765069.xml · derivative · entry 2 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,417 Underlying: Common Stock · 2,417 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:31 UTC |
YARNO WENDY LDirector
|
GrantStock Option (right to buy) · Derivative | 3,837 | $0.00 Strike: $64.34 | $0.00 |
DisclosureSEC source: 0001181186-26-000006 · wk-form4_1782765069.xml · derivative · entry 1 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,837 Underlying: Common Stock · 3,837 shares Expires 2036-06-24 F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:30 UTC |
LINK WILLIAM J PHDDirector
|
GrantRestricted Stock Units · Derivative | 806 | $0.00 | $0.00 |
DisclosureSEC source: 0001228684-26-000008 · wk-form4_1782765039.xml · derivative · entry 3 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 806 Underlying: Common Stock · 806 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:30 UTC |
LINK WILLIAM J PHDDirector
|
GrantRestricted Stock Units · Derivative | 2,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001228684-26-000008 · wk-form4_1782765039.xml · derivative · entry 2 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,417 Underlying: Common Stock · 2,417 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:30 UTC |
LINK WILLIAM J PHDDirector
|
GrantStock Option (right to buy) · Derivative | 3,837 | $0.00 Strike: $64.34 | $0.00 |
DisclosureSEC source: 0001228684-26-000008 · wk-form4_1782765039.xml · derivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,837 Underlying: Common Stock · 3,837 shares Expires 2036-06-24 F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:09 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 5,418 | $61.81 | $334,886.58 |
DisclosureSEC source: 0001827672-26-000009 · wk-form4_1782158996.xml · nonDerivative · entry 2 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Plan reported Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 847,991 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F4 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $61.52 to $62.13. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 20:09 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 4,582 | $61.24 | $280,601.68 |
DisclosureSEC source: 0001827672-26-000009 · wk-form4_1782158996.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Plan reported Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 853,409 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $60.51 to $61.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| June 16, 2026 Filed Jun 17, 2026 20:17 UTC |
Farrow Jeffrey SSee Remarks
|
SaleCommon Stock | 14,396 | $60.95 | $877,436.20 |
DisclosureSEC source: 0001405253-26-000013 · wk-form4_1781727451.xml · nonDerivative · entry 2 Farrow Jeffrey S · CIK 0001405253 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,801 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:17 UTC |
Goodrich KatherineDirector
|
SaleCommon Stock | 2,954 | $62.08 | $183,384.32 |
DisclosureSEC source: 0002044770-26-000006 · wk-form4_1781727435.xml · nonDerivative · entry 1 Goodrich Katherine · CIK 0002044770 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,233 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2026. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:17 UTC |
Farrow Jeffrey SSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 27,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001405253-26-000013 · wk-form4_1781727451.xml · derivative · entry 3 Farrow Jeffrey S · CIK 0001405253 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,882 Underlying: Common Stock · 27,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: RSUs granted on April 24, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service. F4 · derivative.expiration_date: RSUs granted on April 24, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:17 UTC |
Farrow Jeffrey SSee Remarks
|
Exercise / conversionCommon Stock | 27,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001405253-26-000013 · wk-form4_1781727451.xml · nonDerivative · entry 1 Farrow Jeffrey S · CIK 0001405253 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:17 UTC |
LINK WILLIAM J PHDDirector
|
SaleCommon Stock | 1,928 | $62.94 | $121,348.32 |
DisclosureSEC source: 0001228684-26-000006 · wk-form4_1781727420.xml · nonDerivative · entry 2 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,786 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025. F3 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $62.68 to $63.05. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:17 UTC |
LINK WILLIAM J PHDDirector
|
SaleCommon Stock | 10,572 | $61.97 | $655,146.84 |
DisclosureSEC source: 0001228684-26-000006 · wk-form4_1781727420.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,714 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 8, 2025. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $61.67 to $62.67. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 20:05 UTC |
Goodrich KatherineDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,954 | $0.00 | $0.00 |
DisclosureSEC source: 0002044770-26-000004 · wk-form4_1781640353.xml · derivative · entry 2 Goodrich Katherine · CIK 0002044770 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,954 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F3 · derivative.expiration_date: RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 20:05 UTC |
Goodrich KatherineDirector
|
Exercise / conversionCommon Stock | 2,954 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002044770-26-000004 · wk-form4_1781640353.xml · nonDerivative · entry 1 Goodrich Katherine · CIK 0002044770 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,187 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 20:06 UTC |
Morrison Scott WDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001662426-26-000004 · wk-form4_1781640402.xml · derivative · entry 3 Morrison Scott W · CIK 0001662426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,954 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F4 · derivative.expiration_date: RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 20:06 UTC |
Morrison Scott WDirector
|
Exercise / conversionCommon Stock | 2,954 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001662426-26-000004 · wk-form4_1781640402.xml · nonDerivative · entry 1 Morrison Scott W · CIK 0001662426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,638 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| June 12, 2026 Filed Jun 16, 2026 20:06 UTC |
LINK WILLIAM J PHDDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 2,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001228684-26-000004 · wk-form4_1781640385.xml · derivative · entry 2 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,954 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F3 · derivative.expiration_date: RSUs granted on June 12, 2025, in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.